Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo

被引:52
作者
Zhou, Meixia
McPherson, Lisa
Feng, Dongdong
Song, An
Dong, Chen
Lyu, Shu-Chen
Zhou, Lu
Shi, Xiaoyan
Ahn, Yong-Tae
Wang, Demin
Clayberger, Carol
Krensky, Alan M.
机构
[1] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Med Coll Wisconsin, Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
关键词
D O I
10.4049/jimmunol.178.9.5496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kruppel-like transcription factor (KLF)13, previously shown to regulate RANTES expression in vitro, is a member of the Kruppel-like family of transcription factors that controls many growth and developmental processes. To ascertain the function of KLF13 in vivo, Klf3-deficient mice were generated by gene targeting. As expected, activated T lymphocytes from Klf13(-/-) mice show decreased RANTES expression. However, these mice also exhibit enlarged thymi and spleens. TUNEL, as well as spontaneous and activation-induced death assays, demonstrated that prolonged survival of Klf3(-/-) thymocytes was due to decreased apoptosis. Microarray analysis suggests that protection from apoptosis-inducing stimuli in Ktf13(-/-) thymocytes is due in part to increased expression of BCL-X-L, a potent antiapoptotic factor. This finding was confirmed in splenocytes and total thymocytes by real-time quantitative PCR and Western blot as well as in CD4(+)CD8(-) single-positive thymocytes by real-time quantitative PCR. Furthermore, EMSA and luciferase reporter assays demonstrated that KLF13 binds to multiple sites within the Bcl-X-L promoter and results in decreased Bcl-X-L promoter activity, making KLF13 a negative regulator of BCL-X-L.
引用
收藏
页码:5496 / 5504
页数:9
相关论文
共 34 条
[1]   Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes [J].
Ahn, Yong-Tae ;
Huang, Boli ;
McPherson, Lisa ;
Clayberger, Carol ;
Krensky, Alan M. .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) :253-266
[2]   FKLF-2: a novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes [J].
Asano, H ;
Li, XS ;
Stamatoyannopoulos, G .
BLOOD, 2000, 95 (11) :3578-3584
[3]   BCL-X-L-regulated apoptosis in T cell development [J].
Chao, DT ;
Korsmeyer, SJ .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (09) :1375-1384
[4]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[5]   Unanticipated repression function linked to erythroid Kruppel-like factor [J].
Chen, XY ;
Bieker, JJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (09) :3118-3125
[6]   Lung Kruppel-like factor contains an autoinhibitory domain that regulates its transcriptional activation by binding WWP1, an E3 ubiquitin ligase [J].
Conkright, MD ;
Wani, MA ;
Lingrel, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29299-29306
[7]   A novel apoptosis pathway activated by the carboxyl terminus of p21 [J].
Dong, C ;
Li, Q ;
Lyu, SC ;
Krensky, AM ;
Clayberger, C .
BLOOD, 2005, 105 (03) :1187-1194
[8]   Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor [J].
Ellenrieder, V ;
Zhang, JS ;
Kaczynski, J ;
Urrutia, R .
EMBO JOURNAL, 2002, 21 (10) :2451-2460
[9]   Identification and characterization of three new components of the mSin3A corepressor complex [J].
Fleischer, TC ;
Yun, UJ ;
Ayer, DE .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (10) :3456-3467
[10]   Regulation of Bcl-xL:: a little bit of this and a little bit of STAT [J].
Grad, JM ;
Zeng, XR ;
Boise, LH .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (06) :543-549